LSBio
SNAI2 / SLUG Antibody (clone OTI1A6)

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SNAI2 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SNAI2.

SNAI2 / SLUG Antibody (clone OTI1A6)

Primary AntibodyLSBio Guarantee
Antibody:Mouse Monoclonal
Applications:Flow Cytometry, Immunohistochemistry (general), Immunohistochemistry, Paraffin, Western Blot
Reactivity:Human
Format:Liquid
See all Human SNAI2 / SLUG antibodies →
$459.00each
Catalog Number: LS-C175161-100

For bulk orders or custom formulations:

Request a Quote

Overview

Description
SLUG antibody LS-C175161 is an unconjugated mouse monoclonal antibody to human SLUG (SNAI2). Validated for Flow, IHC and WB. Cited in 1 publication.
Application
FC, IHC, IHC-P, WB
Reactivity
Hu
Intended Use
Research Use Only
Guarantees
This antibody carries the LSBio 100% Guarantee.
Category
Antibodies > Primary Antibodies > Monoclonal Antibodies
Alternative Names
SLUG | SLUGH1 | Snail homolog 2 (Drosophila) | SNAIL2 | SLUGH | Protein snail homolog 2 | WS2D | SNAI2 | Zinc finger protein SNAI2
Recommended Dilution: FC
1:100
Recommended Dilution: IHC-P
1:150
Recommended Dilution: WB
1:1000
UniProt Number
O43623
SwissProt
O43623

Target

Target
Human SNAI2 / SLUG
Antigen Species
Human
Epitope
Human SLUG
Gene Name
SNAI2

Antibody

Host Species
Mouse
Clonality
Monoclonal
Clone
OTI1A6
Isotype
IgG1

Immunogen

Immunogen
Full length human recombinant protein of human SNAI2 (NP_003059) produced in E. coli.
Immunogen Type
Full-Length Recombinant Protein

Format

Conjugate/Label
Unconjugated
Format
Liquid
Formulation
PBS, pH 7.3, 0.02% Sodium Azide, 50% Glycerol, 1% BSA
Concentration
1 mg/mL
Volume
100 Microliter
Preservative
Yes
Purification Method
Protein A/G Affinity

Storage & Handling

Storage Conditions
Store at -20°C. Avoid freeze-thaw cycles.
Recommended Storage Buffer
PBS
Histological hallmarks and role of Slug/PIP axis in pulmonary hypertension secondary to pulmonary fibrosis. Ruffenach G, Umar S, Vaillancourt M, Hong J, Cao N, Sarji S, Moazeni S, Cunningham CM, Ardehali A, Reddy ST, Saggar R, Fishbein G, Eghbali M. EMBO molecular medicine. 2019 September;11:e10061. PubMed: 31468711 PMC: PMC6728601

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at: technical@vectorlabs.com.